Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongjun Dang

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Life Metabolism|January 28, 2025
Downregulation of RhoA/ROCK1/YAP/F-actin causing decreased aortic smooth muscle cell stiffness promotes aortic dissection formationWei Zhang, Mengxiao Wang, Enci Wang, et al.
Genes & Diseases|August 9, 2023
A novel <i>in vitro</i> prognostic model of bladder cancer based on urine-derived living tumor cellsJiaqi Wang, Jiying Zhu, Junchi Hu, et al.
Cell Death & Disease|October 21, 2021
Elaiophylin reduces body weight and lowers glucose levels in obese mice by activating AMPKRuoxuan Bao, Yongmei Meng, Haibo Zhang, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinomaWeixue Huang, Liya Ding, Qiang Huang, et al.
The Journal of Clinical Investigation|March 17, 2023
Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expressionXiaobo Wang, Jing Huang, Fenglin Liu, et al.
Life Science Alliance|November 1, 2022
Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosisTian-Xiang Wang, Kun-Long Duan, Zi-Xuan Huang, et al.
Methods in Enzymology|October 10, 2007
Isolation and identification of eukaryotic initiation factor 4A as a molecular target for the marine natural product Pateamine AWoon-Kai Low, Yongjun Dang, Tilman Schneider-Poetsch, et al.
Theranostics|November 23, 2019
p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarizationJinjin Peng, Jiacheng Li, Jing Huang, et al.
European Journal of Medicinal Chemistry|February 13, 2026
Development of the first-in-class RNF4 PROTAC degrader as potential therapeutics for hepatocellular carcinomaHui Wan, Yihang Liu, Huimin Chang, et al.
Nature Chemical Biology|February 1, 2011
XPB, a subunit of TFIIH, is a target of the natural product triptolideDenis V Titov, Benjamin Gilman, Qing-Li He, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Life Metabolism|January 28, 2025
Downregulation of RhoA/ROCK1/YAP/F-actin causing decreased aortic smooth muscle cell stiffness promotes aortic dissection formationWei Zhang, Mengxiao Wang, Enci Wang, et al.
Genes & Diseases|August 9, 2023
A novel <i>in vitro</i> prognostic model of bladder cancer based on urine-derived living tumor cellsJiaqi Wang, Jiying Zhu, Junchi Hu, et al.
Cell Death & Disease|October 21, 2021
Elaiophylin reduces body weight and lowers glucose levels in obese mice by activating AMPKRuoxuan Bao, Yongmei Meng, Haibo Zhang, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinomaWeixue Huang, Liya Ding, Qiang Huang, et al.
The Journal of Clinical Investigation|March 17, 2023
Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expressionXiaobo Wang, Jing Huang, Fenglin Liu, et al.
Life Science Alliance|November 1, 2022
Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosisTian-Xiang Wang, Kun-Long Duan, Zi-Xuan Huang, et al.
Methods in Enzymology|October 10, 2007
Isolation and identification of eukaryotic initiation factor 4A as a molecular target for the marine natural product Pateamine AWoon-Kai Low, Yongjun Dang, Tilman Schneider-Poetsch, et al.
Theranostics|November 23, 2019
p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarizationJinjin Peng, Jiacheng Li, Jing Huang, et al.
European Journal of Medicinal Chemistry|February 13, 2026
Development of the first-in-class RNF4 PROTAC degrader as potential therapeutics for hepatocellular carcinomaHui Wan, Yihang Liu, Huimin Chang, et al.
Nature Chemical Biology|February 1, 2011
XPB, a subunit of TFIIH, is a target of the natural product triptolideDenis V Titov, Benjamin Gilman, Qing-Li He, et al.
Pageof 11